Thermo Fisher Drives Diagnostics Growth with Genedrive Partnership & Strong Market Performance
Thermo Fisher’s $190 bn market cap and Genedrive partnership fuel a strategic push into high‑throughput pharmacogenetic diagnostics, promising new revenue streams and M&A potential.
4 minutes to read